Nov 11, 2016 13:00 pm UTC| Business
SEATTLE and SOUTH SAN FRANCISCO, Ca., Nov. 11, 2016 -- Immune Design, a clinical-stage immunotherapy company focused on oncology, today announced new preclinical data demonstrating the ability of its ZVex discovery...
Nov 11, 2016 13:00 pm UTC| Business
Trial to Assess Potential Effects of MYK-461 Treatment on Arterial Pulse Wave Morphology as Measured by Investigational Optical Biosensor Wristband SOUTH SAN FRANCISCO, Calif., Nov. 11, 2016 -- MyoKardia, Inc....
CSW Industrials Reports Fiscal Second Quarter 2017 Results
Nov 11, 2016 13:00 pm UTC| Business
Highlights Second quarter 2017 net revenue of $80.1 million, compared to $83.7 million in the prior year period.Second quarter 2017 GAAP operating income of $7.0 million; Non-GAAP operating income of $11.5 million.Second...
Hurco Companies, Inc. Announces Quarterly Cash Dividend
Nov 11, 2016 13:00 pm UTC| Business
INDIANAPOLIS, Nov. 11, 2016 -- Hurco Companies, Inc. (Nasdaq:HURC), an international, industrial technology company, announced today that its Board of Directors approved the payment of a cash dividend of $0.09 per...
Nov 11, 2016 13:00 pm UTC| Business
IN THE UNITED STATES DISTRICT COURTFOR THE WESTERN DISTRICT OF TEXASAUSTIN DIVISION KB PARTNERS I, LP Individually andon Behalf of All Other Similarly Situated, Plaintiff, v. PAIN THERAPEUTICS, INC., REMI BARBIER,...
CHMP issues positive opinion recommending Suliqua(TM) (iGlarLixi) for approval in the EU
Nov 11, 2016 12:52 pm UTC| Business
Company announcement - No. 44/2016 CHMP issues positive opinion recommending Suliqua(TM) (iGlarLixi) for approval in the EU Positive opinion based on data from two Phase III studies, LixiLan-O and LixiLan-LFinal...
Nov 11, 2016 12:30 pm UTC| Business
CRANBURY, N.J., Nov. 11, 2016 -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of rare and orphan diseases, today announced that data from the pivotal Phase 3 Study 012 (ATTRACT)...